Exhibit 99.1

FRAMEWORK AGREEMENT

This Framework Agreement (the “Agreement”) is dated as of October 6, 2025 (the “Effective Date”), by and between AutoMax Motors Ltd. (the “Borrower”), SciSparc Ltd. (“Lender”) and SciSparc Merger Sub Ltd. (“Merger Sub”) (the Borrower, Lender and Merger Sub collectively, the “Parties” and individual a “Party”).

R E C I T A L S

WHEREAS, on April 10, 2024, the Parties entered into an Agreement and Plan of Merger, as amended on August 14, 2024, November 26, 2024, March 27, 2025, and on May 8, 2025 (the “Merger Agreement”);

WHEREAS, the Borrower and the Lender entered into a Loan Agreement, dated January 14, 2024, as amended on June 9, 2024, September 5, 2024, and May 8, 2025 (the “Bridge Loan Agreement”) pursuant to which the Lender extended a loan to the Borrower in the principal amount of a $4.25 million (the “Bridge Loan Amount”);

WHEREAS, the Borrower and the Lender entered into a Loan Agreement dated February 24, 2025 (the “New Loan Agreement”, and together with the Bridge Loan Agreement, the “Loan Agreements”) pursuant to which the Lender extended an additional loan to the Borrower in the principal amount of a $2.0 million (the “New Loan Amount”);

WHEREAS, the Parties wish to mutually terminate the Merger Agreement on the terms and conditions set forth herein;

WHEREAS, pursuant to the Bridge Loan Agreement, the Bridge Loan Amount and the interest accrued thereon, shall be due and repaid by the Borrower to the Lender on the third month anniversary of the date of the termination of the Merger Agreement;

WHEREAS, pursuant to the New Loan Agreement, the New Loan Amount shall be repaid by the Borrower to the Lender in monthly installments of $50,000, plus the interest of 8% per annum, compounded annually, accrued on the outstanding New Loan Amount up to each monthly payment date (the “Monthly Payments”);

WHEREAS, the Borrower has failed to deliver 4 Monthly Payments;

WHEREAS, pursuant to the Loan Agreements, the Lender is entitled to accelerate and demand immediate repayment of the entire outstanding amounts of the Bridge Loan Amount and the New Loan Amount, together with all accrued interest thereon; and

WHEREAS, the Borrower and the Lender wish to revise the terms of repayment of the Loan Agreements on the terms and conditions set forth herein.

NOW THEREFORE, the parties agree as follows:

1. Termination of the Merger Agreement. In accordance with Section 9.1(a) of the Merger Agreement, the Parties hereby agree to mutually terminate the Merger Agreement in its entirety effective immediately upon the execution of this Agreement by each of the Parties, such that the Merger Agreement shall be null and void and of no further force or effect.

2. Repayment Terms of Loan Agreements.

(a) Repayment of Bridge Loan Amount. Notwithstanding anything in the Bridge Loan Agreement to the contrary, the outstanding Bridge Loan Amount and the interest of 9% per annum, compounded annually, from the effective date of the Bridge Loan Agreement, shall be repaid by the Borrower to the Lender on January 1, 2028, in one lump-sum payment.

(b) Repayment of New Loan. Notwithstanding anything in the New Loan Agreement to the contrary, the outstanding New Loan Amount shall be repaid by the Borrower to the Lender on the twentieth day of each month commencing on November 20, 2025 (“First Payment”), in monthly installments of $60,000 and the interest of 8% per annum, from the effective date of the New Loan Agreement, compounded annually, accrued on the outstanding New Loan Amount, up to each actual payment date. In addition, together with the First Payment, Borrower shall pay to the Lender all interest accrued on the New Loan Amount from its effective date until the First Payment, in the sum of $114,523. Within 7 business days from the date of execution of this Agreement, the Borrower shall provide the Lender with post-dated checks in advance for all future payments due under this Section, each check corresponding to the amount and due date of each installment. The amount in NIS will be calculated according to the to know official rate of the US$ to the NIS at the date of furnishing the checks.

(c) Events of Default. Notwithstanding anything to the contrary in the Loan Agreements, each of the events set forth below shall be considered an event of default under the Loan Agreements (each, an “Event of Default” and collectively, “Events of Default”):

3. Release. Upon the termination of the Merger Agreement, Borrower, on its own behalf and on behalf of its principals, affiliates, subsidiaries, directors, officers, shareholders, employees, agents, representatives, and successors and assigns of each of them, hereby irrevocably, fully and unconditionally releases and forever discharges Lender and Merger Sub and each of its past or present principals, affiliates, directors, officers, shareholders, employees, agents, representatives, and successors and assigns of each of them, from and against any and all present and future claims, counterclaims, demands, actions, suits, causes of action, damages, controversies and liabilities, including, without limitation, any costs, expenses, bills, penalties or attorneys’ fees, whether know or unknown, contingent or absolute, foreseen or unforeseen, and whether in law, equity or otherwise, that could have been asserted in any court or forum and relating in any way to any conduct, occurrence, activity, expenditure, promise or negotiation arising from or relating to the Merger Agreement.

4. Reservation of Rights. For the avoidance of doubt, nothing in this Agreement shall be construed as or deemed to constitute a waiver of any of the Lender’s rights or remedies under the Loan Agreements and/or any applicable law. The Lender expressly reserves all of its rights and claims in connection with the subject matter hereof.

5. Information. Following the Effective Date, immediately upon the Lender’s request (and in any event, no later than 7 business days from receipt of Lender’s request), Borrower shall deliver to the Lender all information requested by the Lender, including, without limitation: (i) financial information, accountant and auditor reports, and any other information requested by the Lender in connection with the filing, reviewing and auditing of the Lender’s financial statements provided the Borrower is not prohibited to furnish such information to the Lender under any law or regulation or any order issued by the ISA or the court; and (ii) contracts, agreements, debentures, pledges, or other documents relating to the Borrower’s current indebtedness, and provide a list of its current debtholders and their crediting order. The Borrower may require, as a condition to providing the information, that the Lender signs an obligation not to use the information for any purpose other than in connection with the filing, reviewing and auditing of the Lender’s financial statements.

6. Miscellaneous.

(a) This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements or understandings, whether written or oral, relating to such subject matter.

(b) This Agreement shall be governed by and construed in accordance with the laws of the State of Israel, and the competent courts in Jerusalem, Israel shall have exclusive jurisdiction over any dispute arising from this Agreement.

(c) This Agreement may be executed in counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument. Signatures delivered by electronic means shall be deemed valid and binding.

[Signature page to follow]

IN WITNESS WHEREOF, the Parties have executed and delivered this Agreement, or caused it to be executed and delivered by their duly authorized officers, as of the date first above written.

[Signature page Framework Agreement]

Exhibit 99.2

SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors

TEL AVIV, Israel, Oct. 06, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced the entry into a framework agreement for mutual termination of merger, dated October 6, 2025, by and between the Company, AutoMax Motors Ltd. ("AutoMax") and SciSparc Merger Sub Ltd. This agreement outlines key steps to resolve prior commitments and establish clear repayment terms for the Company’s outstanding loans to AutoMax.

The terms of the framework agreement include:

Mutual Termination of Merger Agreement: The parties have mutually agreed to terminate the Agreement and Plan of Merger, dated April 10, 2024, as amended (the "Merger Agreement"), in accordance with Section 9.1(a) thereof. Effective immediately, the Merger Agreement is null and void, with no further force or effect.

Repayment of $4.25 Million Loan: AutoMax will repay the full $4.25 million principal plus 9% per annum interest, compounded annually, in a single lump-sum payment on January 1, 2028, under the terms of the loan agreement dated January 14, 2024, as amended.

Repayment of $2.0 Million Loan: AutoMax will repay the $2.0 million principal in monthly installments of $60,000 each starting November 20, 2025, plus 8% per annum interest, compounded annually up to each payment date. Additionally, all accrued interest from the loan's effective date (February 24, 2025) through November 20, 2025, totaling $114,523, will be paid at the outset.

About SciSparc Ltd. (Nasdaq: SPRC):

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. SciSparc’s focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette Syndrome, for the treatment of Alzheimer’s disease and agitation; and SCI-210 for the treatment of ASD and status epilepticus. The Company also owns a controlling interest in a subsidiary whose business focuses on the sale of hemp seed oil-based products on the Amazon.com Marketplace.

Forward-Looking Statements:

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. For example, SciSparc is using forward-looking statements when it discusses repayment terms and timing thereof of the Company’s loans to AutoMax. Because such statements deal with future events and are based on SciSparc’s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of SciSparc could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in SciSparc’s Annual Report on Form 20-F filed with the SEC on April 24, 2025, and in subsequent filings with the SEC. Except as otherwise required by law, SciSparc disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events or circumstances or otherwise.

Investor Contact:

IR@scisparc.com

Tel: +972 3-761-7108